Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics

Patent ExpiryDNA Polymerase IIIC InhibitorPositive

AI Analysis

Summary

Acurx Pharmaceuticals announced that the Japan and Mexico Patent Offices have both granted new patents for its DNA Polymerase IIIC Inhibitor class of small molecule antibiotics. This expands the company's patent protection for its difficult-to-treat bacterial infection therapeutic program.

Outcome Details

Japan and Mexico Patent Offices granted new patents for DNA Polymerase IIIC Inhibitor Antibiotics

Importance:4/10

Sentiment:

0.60

patentantibioticsinternationalDNA Polymerase IIICJapanMexico

Related Companies

$ACXP

Read the original article

Published by PR Newswire Biotech on August 12, 2026 12:01 PM

Read Original